VentureBeat November 1, 2024
DevRev

Palo Alto, CA — October 2024 — Following its successful Series A funding round in August 2024, where DevRev secured $100.8 million and reached a $1.15 billion valuation, the company continues to drive forward its mission to revolutionize customer support and product development. Led by Khosla Ventures with participation from Mayfield Fund, Param Hansa Values, U First Capital, and several accelerators, family offices, and angel investors, this investment highlights the growing potential of AI-native enterprise software.

Fueling this mission is DevRev’s AgentOS platform, which is rapidly advancing GenAI adoption in enterprises. By offering seamless 1-click data migration from legacy systems and deploying lightweight AI agents, DevRev is setting a new standard for how businesses integrate and benefit from AI.

...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Investments, Technology, Trends
How rural hospitals, Silicon Valley can head off the AI digital divide
Enhancing primary care: The impact of pharmacist-led chronic care and AI-driven telehealth
Report: AWS CEO Says Agentic AI Could Be Company’s ‘Next Multibillion Business’
The Future of Clinical Care is AI-Driven. Here's How Hospital Leaders Are Preparing.
Your Business Uses AI—Do You Know Who Is Responsible For It?

Share This Article